The possible therapeutic effects of OLT1177 for AD was examined using cognitive function assessment in the APP/PS1 mouse and by characterizing underlying cellular mechanisms ranging from systems metabolism to neuronal function, from structural analysis to inflammatory processes. This evidence concerns the gene APP and Alzheimer disease.